Daniel Ramirez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Daniel Ramirez has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Alyssa Kipke
Division of Hematology and Oncology, Department of Internal Medicine, Ascension Genesys Hospital, Grand Blanc, MI 48439, USA
1 shared publication Aram Minasian
Department of Internal Medicine, Ascension Genesys Hospital, Grand Blanc, Michigan, USA
1 shared publication- Brandon Wiggins
Internal Medicine, Ascension Genesys Hospital, Grand Blanc, USA
1 shared publication - Daniel Taylor
Division of Hematology and Oncology, Department of Internal Medicine, Ascension Genesys Hospital, Grand Blanc, MI 48439, USA
1 shared publication Graham Appelbe
Department of Internal Medicine, Ascension Genesys Medical Center, Grand Blanc, MI, USA
1 shared publication- Jared Hicken
Base Medical Student, Ascension Genesys Hospital, Grand Blanc, Michigan, USA
1 shared publication
Latest Publications
- Open Access
- 21 September 2022
- Published by MDPI AG in Hematology Reports
- Vol. 14 (4) , 290-293
Medication-Induced Factor V Inhibition in the Setting of Refractory Coagulopathy
Liver cirrhosis is commonly associated with coagulopathies, typically demonstrated by elevated prothrombin time, international normalized ratio, and partial thromboplastin time. In the setting of bleeding related to coagulopathies, oftentimes physicians try to reverse coagulopathy through a variety of methods including the use of vitamin K and fresh frozen plasma. Rarely, attempts at reversing coagulopathy are unsuccessful due to severe disease or factor inhibitors. The treatment of acquired factor V inhibitors is primarily performed through immunosuppression and supportive care for the initial bleeding episode. Early detection and treatment of factor V inhibition is challenging in a setting of underlying cirrhosis-related coagulopathy.
- 21 September 2022
- Published by MDPI AG in Hematology Reports
- Vol. 14 (4) , 290-293
Open AccessMedication-Induced Factor V Inhibition in the Setting of Refractory Coagulopathy
Liver cirrhosis is commonly associated with coagulopathies, typically demonstrated by elevated prothrombin time, international normalized ratio, and partial thromboplastin time. In the setting of bleeding related to coagulopathies, oftentimes physicians try to reverse coagulopathy through a variety of methods including the use of vitamin K and fresh frozen plasma. Rarely, attempts at reversing coagulopathy are unsuccessful due to severe disease or factor inhibitors. The treatment of acquired factor V inhibitors is primarily performed through immunosuppression and supportive care for the initial bleeding episode. Early detection and treatment of factor V inhibition is challenging in a setting of underlying cirrhosis-related coagulopathy.
- Open Access
- 31 January 2021
- Published by Hindawi Limited in Case Reports in Neurological Medicine
- Vol. 2021, 1-4
Stiff-Person Syndrome: Seeing Past Comorbidities to Reach the Correct Diagnosis
Stiff-person syndrome (SPS) is a rare disorder seen in approximately one in one million people. Although it is rare, the symptoms and findings of a typical case should paint a clear clinical picture for those who are familiar with the disease. The primary findings in SPS include progressive axial muscle rigidity as well as muscle spasms. These symptoms most commonly occur in the setting of antibodies against Glutamic Acid Decarboxylase (GAD), the rate-limiting enzyme in the production of Gamma-Aminobutyric Acid (GABA), which is the primary inhibitory enzyme in the central nervous system. Here, we report the case of a 65-year-old African-American female with a past medical history of hypothyroidism, anxiety, and depression with psychotic features who presented with axial muscle rigidity and lactic acidosis. She had been symptomatic for several months and reported extensive workups performed at two previous hospitals without a definitive diagnosis. A complete neurological and musculoskeletal investigation yielded no positive findings except for the presence of GAD antibodies. The patient was treated with diazepam, tizanidine, and Intravenous Immunoglobulin (IVIG) with significant improvement, thus solidifying the diagnosis of SPS, a rare autoimmune and/or paraneoplastic syndrome.
- 31 January 2021
- Published by Hindawi Limited in Case Reports in Neurological Medicine
- Vol. 2021, 1-4
Open AccessStiff-Person Syndrome: Seeing Past Comorbidities to Reach the Correct Diagnosis
Stiff-person syndrome (SPS) is a rare disorder seen in approximately one in one million people. Although it is rare, the symptoms and findings of a typical case should paint a clear clinical picture for those who are familiar with the disease. The primary findings in SPS include progressive axial muscle rigidity as well as muscle spasms. These symptoms most commonly occur in the setting of antibodies against Glutamic Acid Decarboxylase (GAD), the rate-limiting enzyme in the production of Gamma-Aminobutyric Acid (GABA), which is the primary inhibitory enzyme in the central nervous system. Here, we report the case of a 65-year-old African-American female with a past medical history of hypothyroidism, anxiety, and depression with psychotic features who presented with axial muscle rigidity and lactic acidosis. She had been symptomatic for several months and reported extensive workups performed at two previous hospitals without a definitive diagnosis. A complete neurological and musculoskeletal investigation yielded no positive findings except for the presence of GAD antibodies. The patient was treated with diazepam, tizanidine, and Intravenous Immunoglobulin (IVIG) with significant improvement, thus solidifying the diagnosis of SPS, a rare autoimmune and/or paraneoplastic syndrome.
- Open Access
- 16 November 2020
- Published by Wiley in Case Reports in Gastrointestinal Medicine
- Vol. 2020, 1-4
A Rare Complication of Noncompliance Status Post-Transhiatal Esophagectomy and Esophago-Gastroanastomosis
Gastropleural fistulas are a complication of peptic ulcers in hiatal hernias, trauma, infections, surgical complications, and malignancy. Presenting symptoms may include gastric and chest pain with respiratory failure in the setting of pneumonitis, hydropneumothorax, or tension pneumothorax. We describe a 57-year-old male with a history of transhiatal esophagectomy and esophago-gastroanastomosis who presented in the setting of dyspnea and dark orogastric tube output. Upper endoscopy revealed multiple gastric ulcers with a dominant ulceration communicating with an adjacent space, and a fistulous tract was demonstrated on computed tomography chest, confirming a gastropleural fistula, a rare life-threatening condition.
- 16 November 2020
- Published by Wiley in Case Reports in Gastrointestinal Medicine
- Vol. 2020, 1-4
Open AccessA Rare Complication of Noncompliance Status Post-Transhiatal Esophagectomy and Esophago-Gastroanastomosis
Gastropleural fistulas are a complication of peptic ulcers in hiatal hernias, trauma, infections, surgical complications, and malignancy. Presenting symptoms may include gastric and chest pain with respiratory failure in the setting of pneumonitis, hydropneumothorax, or tension pneumothorax. We describe a 57-year-old male with a history of transhiatal esophagectomy and esophago-gastroanastomosis who presented in the setting of dyspnea and dark orogastric tube output. Upper endoscopy revealed multiple gastric ulcers with a dominant ulceration communicating with an adjacent space, and a fistulous tract was demonstrated on computed tomography chest, confirming a gastropleural fistula, a rare life-threatening condition.